Saturday, October 31, 2026

EUR/CHF Went Up By Over 1% In The Last 10 Sessions

EUR/CHF Went Up By Over 1% In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.45% for the last 10 sessions. At 08:06 EST on Wednesday, 22 May, EUR/CHF (EURCHF) is $0.99.

EUR/CHF's yearly highs and lows, it's 9.712% up from its 52-week low and 0.081% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was 0.22%, 0.09%, and 0.22%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.22% (last week), 0.21% (last month), and 0.22% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy trades on a stronger note above 155.50, investors await fedspeak. According to FXStreet on Monday, 20 May, "The USD/JPY pair trades in positive territory for the third consecutive trading day around 155.80 during the early Asian session on Monday. "
  • Usd/jpy continues winning spell on fed’s hawkish interest rate outlook. According to FXStreet on Tuesday, 21 May, "The USD/JPY pair extends its winning spell for the fourth trading session on Tuesday. ", "This week, the USD/JPY pair will dance to the tunes of the Federal Open Market Committee (FOMC) minutes for the May meeting and Japan's National Consumer Price Index (CPI) data for April, which will be published on Wednesday and Friday."
  • Usd/jpy price analysis: sideways below 156.50 as US yields fall. According to FXStreet on Tuesday, 21 May, "Despite standing in bullish territory, if the RSI punches below the 50-midline, that could pave the way for USD/JPY losses.", "On the flip side, and the most likely path in the near term, if USD/JPY tumbles below 156.00, the first support would be the Senkou Span A at 155.61. "
  • Usd/jpy price analysis: hits three-day high as bulls eye 157.00. According to FXStreet on Monday, 20 May, "US Treasury bond yields advance, particularly the 10-year Treasury note yield, which correlates positively to the USD/JPY pair. ", "The USD/JPY daily chart shows the pair remains tilted to the upside, yet it's far from testing the latest cycle high. "
  • According to FXStreet on Wednesday, 22 May, "The USD/JPY pair could retest the upper boundary of the ascending triangle near the psychological barrier at 157.00. ", "A break below this level could exert downward pressure on the USD/JPY pair, potentially moving it toward the throwback support at 153.60."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com